MDxHealth SA
MDXH
$2.04
$0.073.55%
NASDAQ
| 12/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 90.05M | 84.71M | 80.74M | 75.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 90.05M | 84.71M | 80.74M | 75.33M |
| Cost of Revenue | -- | 34.91M | 32.41M | 30.17M | 28.05M |
| Gross Profit | -- | 55.14M | 52.30M | 50.57M | 47.28M |
| SG&A Expenses | -- | 63.78M | 63.43M | 61.51M | 59.71M |
| Depreciation & Amortization | -- | 4.91M | 8.07M | 7.87M | 8.99M |
| Other Operating Expenses | -- | 381.00K | -253.00K | -254.00K | -272.00K |
| Total Operating Expenses | -- | 114.53M | 110.89M | 105.39M | 100.54M |
| Operating Income | -- | -24.48M | -26.18M | -24.65M | -25.21M |
| Income Before Tax | -- | -37.68M | -41.60M | -40.80M | -39.90M |
| Income Tax Expenses | -- | 392.00K | 345.00K | 1.00K | 1.00K |
| Earnings from Continuing Operations | -- | -38.07 | -41.95 | -40.80 | -39.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -38.07M | -41.95M | -40.80M | -39.90M |
| EBIT | -- | -24.48M | -26.18M | -24.65M | -25.21M |
| EBITDA | -- | -17.96M | -18.75M | -17.50M | -18.09M |
| EPS Basic | -- | -1.27 | -1.52 | -1.49 | -1.48 |
| Normalized Basic EPS | -- | -0.16 | -0.20 | -0.20 | -0.25 |
| EPS Diluted | -- | -1.27 | -1.52 | -1.49 | -1.48 |
| Normalized Diluted EPS | -- | -0.16 | -0.20 | -0.20 | -0.25 |
| Average Basic Shares Outstanding | -- | 131.74M | 110.36M | 109.54M | 107.76M |
| Average Diluted Shares Outstanding | -- | 131.74M | 110.36M | 109.54M | 107.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |